Journal
ANALYTICAL CHEMISTRY
Volume 91, Issue 24, Pages 15818-15825Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acs.analchem.9b04118
Keywords
-
Categories
Funding
- National Key R&D Program of China [2018YFC1312301, 2018YFC2000305]
- National Natural Science Foundation of China [81570060, 31870826]
- National Clinical Research Center for Geriatrics of West China Hospital at Sichuan University [Z20191001]
Ask authors/readers for more resources
Activity-based chemical proteomics approaches used for identifying cellular targets of drugs are mainly dependent on the availability of probes derived from drugs. However, all chemical probes are structurally different from the drugs themselves and cannot fully mimic the real actions of drugs in cells. Here we present a concise and unbiased immunoaffinity-based strategy for identifying covalent drug targets in vivo. By using the specific antibody, we not only confirm the well-known ibrutinib-binding target BTK, but also identify some previously undescribed strongly binding proteins, such as CKAP4 in human cell lines and TAP1 in mouse organs. The observed target profiles between species may partially explain why certain drug candidates are very effective in mice but not in humans. This approach avoids the chemical modification of drugs, eliminates the nonspecific bindings of chemical probes, and allows to unbiasedly decode the underlying mechanisms of action of covalent drugs.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available